The LTMP works to improve the basic understanding of thoracic cancer biology and genetics and to apply this knowledge to translational research goals. The LTMP has research strength in areas that comprise five major themes: (1) new therapeutic targets and novel therapeutic delivery; (2) inflammation and immune cells in lung cancer; (3) early detection/biomarkers for thoracic cancers; (4) genetic susceptibility to thoracic cancers; and (5) clinical studies.
Read more about the Lung and Thoracic Malignancies Program
Research Themes:
Defining molecular pathways that contribute to the development and progression of lung and thoracic malignancies
Chronic lung inflammatory responses and the role of host immune response in reducing recurrence rates
Biomarkers for early detection of lung and thoracic cancers
Identifying genetic or carcinogen-induced mutations that lead to lung cancer
Investigator-initiated therapeutic clinical trials in lung cancer
